Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychoactive Substances Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Stimulants
1.2.3 Cannabinoids
1.2.4 Hallucinogens
1.2.5 Depressants
1.3 Market by Application
1.3.1 Global Psychoactive Substances Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Cancer
1.3.3 Neuropathic Disorders
1.3.4 Spasticity
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psychoactive Substances Market Perspective (2024-2034)
2.2 Psychoactive Substances Growth Trends by Region
2.2.1 Global Psychoactive Substances Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Psychoactive Substances Historic Market Size by Region (2024-2024)
2.2.3 Psychoactive Substances Forecasted Market Size by Region (2024-2034)
2.3 Psychoactive Substances Market Dynamics
2.3.1 Psychoactive Substances Industry Trends
2.3.2 Psychoactive Substances Market Drivers
2.3.3 Psychoactive Substances Market Challenges
2.3.4 Psychoactive Substances Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychoactive Substances Players by Revenue
3.1.1 Global Top Psychoactive Substances Players by Revenue (2024-2024)
3.1.2 Global Psychoactive Substances Revenue Market Share by Players (2024-2024)
3.2 Global Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Psychoactive Substances Revenue
3.4 Global Psychoactive Substances Market Concentration Ratio
3.4.1 Global Psychoactive Substances Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychoactive Substances Revenue in 2022
3.5 Psychoactive Substances Key Players Head office and Area Served
3.6 Key Players Psychoactive Substances Product Solution and Service
3.7 Date of Enter into Psychoactive Substances Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychoactive Substances Breakdown Data by Type
4.1 Global Psychoactive Substances Historic Market Size by Type (2024-2024)
4.2 Global Psychoactive Substances Forecasted Market Size by Type (2024-2034)
5 Psychoactive Substances Breakdown Data by Application
5.1 Global Psychoactive Substances Historic Market Size by Application (2024-2024)
5.2 Global Psychoactive Substances Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Psychoactive Substances Market Size (2024-2034)
6.2 North America Psychoactive Substances Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Psychoactive Substances Market Size by Country (2024-2024)
6.4 North America Psychoactive Substances Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psychoactive Substances Market Size (2024-2034)
7.2 Europe Psychoactive Substances Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Psychoactive Substances Market Size by Country (2024-2024)
7.4 Europe Psychoactive Substances Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psychoactive Substances Market Size (2024-2034)
8.2 Asia-Pacific Psychoactive Substances Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Psychoactive Substances Market Size by Region (2024-2024)
8.4 Asia-Pacific Psychoactive Substances Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psychoactive Substances Market Size (2024-2034)
9.2 Latin America Psychoactive Substances Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Psychoactive Substances Market Size by Country (2024-2024)
9.4 Latin America Psychoactive Substances Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychoactive Substances Market Size (2024-2034)
10.2 Middle East & Africa Psychoactive Substances Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Psychoactive Substances Market Size by Country (2024-2024)
10.4 Middle East & Africa Psychoactive Substances Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Detail
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals Psychoactive Substances Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in Psychoactive Substances Business (2024-2024)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 GW Pharmaceuticals PLC.
11.2.1 GW Pharmaceuticals PLC. Company Detail
11.2.2 GW Pharmaceuticals PLC. Business Overview
11.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Introduction
11.2.4 GW Pharmaceuticals PLC. Revenue in Psychoactive Substances Business (2024-2024)
11.2.5 GW Pharmaceuticals PLC. Recent Development
11.3 Enecta.
11.3.1 Enecta. Company Detail
11.3.2 Enecta. Business Overview
11.3.3 Enecta. Psychoactive Substances Introduction
11.3.4 Enecta. Revenue in Psychoactive Substances Business (2024-2024)
11.3.5 Enecta. Recent Development
11.4 Teewinot Life Sciences
11.4.1 Teewinot Life Sciences Company Detail
11.4.2 Teewinot Life Sciences Business Overview
11.4.3 Teewinot Life Sciences Psychoactive Substances Introduction
11.4.4 Teewinot Life Sciences Revenue in Psychoactive Substances Business (2024-2024)
11.4.5 Teewinot Life Sciences Recent Development
11.5 GD Pharma
11.5.1 GD Pharma Company Detail
11.5.2 GD Pharma Business Overview
11.5.3 GD Pharma Psychoactive Substances Introduction
11.5.4 GD Pharma Revenue in Psychoactive Substances Business (2024-2024)
11.5.5 GD Pharma Recent Development
11.6 Cape Bouvard Technologies Pty Ltd
11.6.1 Cape Bouvard Technologies Pty Ltd Company Detail
11.6.2 Cape Bouvard Technologies Pty Ltd Business Overview
11.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Introduction
11.6.4 Cape Bouvard Technologies Pty Ltd Revenue in Psychoactive Substances Business (2024-2024)
11.6.5 Cape Bouvard Technologies Pty Ltd Recent Development
11.7 AusCann Group Holdings Pty Ltd.
11.7.1 AusCann Group Holdings Pty Ltd. Company Detail
11.7.2 AusCann Group Holdings Pty Ltd. Business Overview
11.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Introduction
11.7.4 AusCann Group Holdings Pty Ltd. Revenue in Psychoactive Substances Business (2024-2024)
11.7.5 AusCann Group Holdings Pty Ltd. Recent Development
11.8 Cannabics Pharmaceuticals Inc.
11.8.1 Cannabics Pharmaceuticals Inc. Company Detail
11.8.2 Cannabics Pharmaceuticals Inc. Business Overview
11.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Introduction
11.8.4 Cannabics Pharmaceuticals Inc. Revenue in Psychoactive Substances Business (2024-2024)
11.8.5 Cannabics Pharmaceuticals Inc. Recent Development
11.9 Alpha-CAT
11.9.1 Alpha-CAT Company Detail
11.9.2 Alpha-CAT Business Overview
11.9.3 Alpha-CAT Psychoactive Substances Introduction
11.9.4 Alpha-CAT Revenue in Psychoactive Substances Business (2024-2024)
11.9.5 Alpha-CAT Recent Development
11.10 Tilray
11.10.1 Tilray Company Detail
11.10.2 Tilray Business Overview
11.10.3 Tilray Psychoactive Substances Introduction
11.10.4 Tilray Revenue in Psychoactive Substances Business (2024-2024)
11.10.5 Tilray Recent Development
11.11 Cyrelian Pty Ltd.
11.11.1 Cyrelian Pty Ltd. Company Detail
11.11.2 Cyrelian Pty Ltd. Business Overview
11.11.3 Cyrelian Pty Ltd. Psychoactive Substances Introduction
11.11.4 Cyrelian Pty Ltd. Revenue in Psychoactive Substances Business (2024-2024)
11.11.5 Cyrelian Pty Ltd. Recent Development
11.12 MedReleaf Australia
11.12.1 MedReleaf Australia Company Detail
11.12.2 MedReleaf Australia Business Overview
11.12.3 MedReleaf Australia Psychoactive Substances Introduction
11.12.4 MedReleaf Australia Revenue in Psychoactive Substances Business (2024-2024)
11.12.5 MedReleaf Australia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Psychoactive Substances Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Stimulants
Table 3. Key Players of Cannabinoids
Table 4. Key Players of Hallucinogens
Table 5. Key Players of Depressants
Table 6. Global Psychoactive Substances Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Psychoactive Substances Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Psychoactive Substances Market Size by Region (2024-2024) & (US$ Million)
Table 9. Global Psychoactive Substances Market Share by Region (2024-2024)
Table 10. Global Psychoactive Substances Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Psychoactive Substances Market Share by Region (2024-2034)
Table 12. Psychoactive Substances Market Trends
Table 13. Psychoactive Substances Market Drivers
Table 14. Psychoactive Substances Market Challenges
Table 15. Psychoactive Substances Market Restraints
Table 16. Global Psychoactive Substances Revenue by Players (2024-2024) & (US$ Million)
Table 17. Global Psychoactive Substances Market Share by Players (2024-2024)
Table 18. Global Top Psychoactive Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
Table 19. Ranking of Global Top Psychoactive Substances Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Psychoactive Substances Revenue (CR5 and HHI) & (2024-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psychoactive Substances Product Solution and Service
Table 23. Date of Enter into Psychoactive Substances Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psychoactive Substances Market Size by Type (2024-2024) & (US$ Million)
Table 26. Global Psychoactive Substances Revenue Market Share by Type (2024-2024)
Table 27. Global Psychoactive Substances Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Psychoactive Substances Revenue Market Share by Type (2024-2034)
Table 29. Global Psychoactive Substances Market Size by Application (2024-2024) & (US$ Million)
Table 30. Global Psychoactive Substances Revenue Market Share by Application (2024-2024)
Table 31. Global Psychoactive Substances Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Psychoactive Substances Revenue Market Share by Application (2024-2034)
Table 33. North America Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 34. North America Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 35. North America Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. Europe Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 38. Europe Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Psychoactive Substances Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Asia-Pacific Psychoactive Substances Market Size by Region (2024-2024) & (US$ Million)
Table 41. Asia-Pacific Psychoactive Substances Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Latin America Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 44. Latin America Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Middle East & Africa Psychoactive Substances Market Size by Country (2024-2024) & (US$ Million)
Table 47. Middle East & Africa Psychoactive Substances Market Size by Country (2024-2034) & (US$ Million)
Table 48. Zynerba Pharmaceuticals Company Detail
Table 49. Zynerba Pharmaceuticals Business Overview
Table 50. Zynerba Pharmaceuticals Psychoactive Substances Product
Table 51. Zynerba Pharmaceuticals Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 52. Zynerba Pharmaceuticals Recent Development
Table 53. GW Pharmaceuticals PLC. Company Detail
Table 54. GW Pharmaceuticals PLC. Business Overview
Table 55. GW Pharmaceuticals PLC. Psychoactive Substances Product
Table 56. GW Pharmaceuticals PLC. Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 57. GW Pharmaceuticals PLC. Recent Development
Table 58. Enecta. Company Detail
Table 59. Enecta. Business Overview
Table 60. Enecta. Psychoactive Substances Product
Table 61. Enecta. Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 62. Enecta. Recent Development
Table 63. Teewinot Life Sciences Company Detail
Table 64. Teewinot Life Sciences Business Overview
Table 65. Teewinot Life Sciences Psychoactive Substances Product
Table 66. Teewinot Life Sciences Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 67. Teewinot Life Sciences Recent Development
Table 68. GD Pharma Company Detail
Table 69. GD Pharma Business Overview
Table 70. GD Pharma Psychoactive Substances Product
Table 71. GD Pharma Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 72. GD Pharma Recent Development
Table 73. Cape Bouvard Technologies Pty Ltd Company Detail
Table 74. Cape Bouvard Technologies Pty Ltd Business Overview
Table 75. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product
Table 76. Cape Bouvard Technologies Pty Ltd Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 77. Cape Bouvard Technologies Pty Ltd Recent Development
Table 78. AusCann Group Holdings Pty Ltd. Company Detail
Table 79. AusCann Group Holdings Pty Ltd. Business Overview
Table 80. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product
Table 81. AusCann Group Holdings Pty Ltd. Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 82. AusCann Group Holdings Pty Ltd. Recent Development
Table 83. Cannabics Pharmaceuticals Inc. Company Detail
Table 84. Cannabics Pharmaceuticals Inc. Business Overview
Table 85. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product
Table 86. Cannabics Pharmaceuticals Inc. Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 87. Cannabics Pharmaceuticals Inc. Recent Development
Table 88. Alpha-CAT Company Detail
Table 89. Alpha-CAT Business Overview
Table 90. Alpha-CAT Psychoactive Substances Product
Table 91. Alpha-CAT Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 92. Alpha-CAT Recent Development
Table 93. Tilray Company Detail
Table 94. Tilray Business Overview
Table 95. Tilray Psychoactive Substances Product
Table 96. Tilray Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 97. Tilray Recent Development
Table 98. Cyrelian Pty Ltd. Company Detail
Table 99. Cyrelian Pty Ltd. Business Overview
Table 100. Cyrelian Pty Ltd. Psychoactive Substances Product
Table 101. Cyrelian Pty Ltd. Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 102. Cyrelian Pty Ltd. Recent Development
Table 103. MedReleaf Australia Company Detail
Table 104. MedReleaf Australia Business Overview
Table 105. MedReleaf Australia Psychoactive Substances Product
Table 106. MedReleaf Australia Revenue in Psychoactive Substances Business (2024-2024) & (US$ Million)
Table 107. MedReleaf Australia Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychoactive Substances Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Psychoactive Substances Market Share by Type: 2022 VS 2034
Figure 3. Stimulants Features
Figure 4. Cannabinoids Features
Figure 5. Hallucinogens Features
Figure 6. Depressants Features
Figure 7. Global Psychoactive Substances Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Psychoactive Substances Market Share by Application: 2022 VS 2034
Figure 9. Cancer Case Studies
Figure 10. Neuropathic Disorders Case Studies
Figure 11. Spasticity Case Studies
Figure 12. Psychoactive Substances Report Years Considered
Figure 13. Global Psychoactive Substances Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Psychoactive Substances Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Psychoactive Substances Market Share by Region: 2022 VS 2034
Figure 16. Global Psychoactive Substances Market Share by Players in 2022
Figure 17. Global Top Psychoactive Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Psychoactive Substances Revenue in 2022
Figure 19. North America Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Psychoactive Substances Market Share by Country (2024-2034)
Figure 21. United States Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Psychoactive Substances Market Share by Country (2024-2034)
Figure 25. Germany Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Psychoactive Substances Market Share by Region (2024-2034)
Figure 33. China Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Psychoactive Substances Market Share by Country (2024-2034)
Figure 41. Mexico Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Psychoactive Substances Market Share by Country (2024-2034)
Figure 45. Turkey Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Psychoactive Substances Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Zynerba Pharmaceuticals Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 48. GW Pharmaceuticals PLC. Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 49. Enecta. Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 50. Teewinot Life Sciences Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 51. GD Pharma Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 52. Cape Bouvard Technologies Pty Ltd Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 53. AusCann Group Holdings Pty Ltd. Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 54. Cannabics Pharmaceuticals Inc. Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 55. Alpha-CAT Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 56. Tilray Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 57. Cyrelian Pty Ltd. Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 58. MedReleaf Australia Revenue Growth Rate in Psychoactive Substances Business (2024-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed